BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2187277)

  • 1. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K; Langmark F
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical mass screening in Norway--510,000 smears a year.
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Cancer Detect Prev; 1994; 18(6):463-70. PubMed ID: 7867019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of organized screening for uterine cervix cancer in Denmark during 1968-1987].
    Lynge E; Engholm G; Madsen M
    Ugeskr Laeger; 1992 May; 154(19):1330-4. PubMed ID: 1598705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screening programme for cervical cancer that worked.
    Hakama M; Louhivuori K
    Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No effect of organized cervix cancer screening].
    Zahl PH
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1302; author reply 1302. PubMed ID: 18511980
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B; Grinsted P
    Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status of preventive screening for uterine cervix cancer in Denmark in 1994].
    Lynge E; Arffmann E; Erbs K; Hansen KC; Henriksen B; Holten IW; Hølund B; Jakobsen AB; Jespersen NB; Olesen F
    Ugeskr Laeger; 1994 Jan; 156(4):471-3. PubMed ID: 8140664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytological mass screening in Ostfold County, Norway.
    Magnus K; Langmark F
    IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of the Pap-test in the cervical cytological screening].
    Giannone R; Piacezzi C; Poli M; Bernorio R
    Minerva Ginecol; 1992 Apr; 44(4):155-9. PubMed ID: 1584446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organization and results of cervical cancer screening in the German Democratic Republic.
    Ebeling K; Nischan P
    IARC Sci Publ; 1986; (76):251-66. PubMed ID: 3570410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.